RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
All Swissmedic updates
Swissmedic
REGULATORY UPDATE
Revision of the Swissmedic Fees Ordinance on 1 July 2026
Published: 6/19/2026Detected: 6/19/2026

Summary preview

Revises the Swissmedic Fees Ordinance with effect from 1 July 2026, adjusting the fee framework that applicants and licence holders must budget for during Swiss regulatory interactions.

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

Create free account
#Swissmedic
#fees
#ordinance
#submission
#authorization

Official Source Document
Source Verified

Access the original document directly from SWISSMEDIC.

View Official Document

More from Swissmedic

  • Changes to the Guidance document “Import of a human medicinal product according to Art. 14 para. 2 and 3 TPA (parallel import)”10/1/2026
  • Adaptations required for issuing establishment licences and GMP certificates for manufacturers of active substances10/1/2026
  • Revision of the Guidance document Authorisation Biosimilar10/1/2026
  • Swissmedic Portal Release – New Features Available from 23 September 20269/24/2026
  • I-SMI.TI.22e Notifications according to Article 41, MPLO9/23/2026

Get Swissmedic alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
  • Security
  • Privacy Policy
  • Terms of Service

    • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.